High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$349M
$349,999,986
Total Sells (Filtered)
$1.8M
$1,772,501
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| IMVT |
Immunovant, Inc.
|
COO
Sell to Cover
|
2026-02-25 | $38,770 | S | Form 4 |
| IMVT |
Immunovant, Inc.
|
COO
Sell to Cover
|
2026-02-25 | $27,224 | S | Form 4 |
| IMVT |
Immunovant, Inc.
|
COO
Sell to Cover
|
2026-02-25 | $24,189 | S | Form 4 |
| IMVT |
Immunovant, Inc.
|
CTO
Sell to Cover
|
2026-01-21 | $51,461 | S | Form 4 |
| IMVT |
Immunovant, Inc.
|
CTO
Sell to Cover
|
2026-01-07 | $30,433 | S | Form 4 |
| IMVT |
Immunovant, Inc.
|
CTO
Sell to Cover
|
2026-01-07 | $1,481 | S | Form 4 |
|
IMVT
S
Immunovant, Inc.
Van Tuyl Christopher
• Officer • Chief Legal Officer
Sell to Cover
2025-12-18
$228,407
|
||||||
| IMVT |
Immunovant, Inc.
|
Officer • Chief Legal Officer
Sell to Cover
|
2025-12-18 | $228,407 | S | Form 4 |
|
IMVT
S
Immunovant, Inc.
Van Tuyl Christopher
• Officer • Chief Legal Officer
Sell to Cover
2025-12-18
$62,536
|
||||||
| IMVT |
Immunovant, Inc.
|
Officer • Chief Legal Officer
Sell to Cover
|
2025-12-18 | $62,536 | S | Form 4 |
|
IMVT
P
Immunovant, Inc.
Roivant Sciences Ltd.
• Director
Discretionary BuyΔOwn +17.2%
2025-12-12
$349,999,986MEGA
|
||||||
| IMVT |
Immunovant, Inc.
|
Director
Discretionary BuyΔOwn +17.2%
|
2025-12-12 | $349,999,986MEGA | P | Form 4 |
| IMVT |
Immunovant, Inc.
|
Director
10b5-1 Sell
|
2025-12-01 | $69,407 | S | Form 4 |
| IMVT |
Immunovant, Inc.
|
Director
10b5-1 Sell
|
2025-12-01 | $302,926 | S | Form 4 |
| IMVT |
Immunovant, Inc.
|
Director
10b5-1 Sell
|
2025-12-01 | $45,740 | S | Form 4 |
| IMVT |
Immunovant, Inc.
|
Director
10b5-1 SellΔOwn -17.9%
|
2025-12-01 | $447,782 | S | Form 4 |
| IMVT |
Immunovant, Inc.
|
COO
Sell to Cover
|
2025-11-20 | $241,309 | S | Form 4 |
| IMVT |
Immunovant, Inc.
|
COO
Sell to Cover
|
2025-11-20 | $56,929 | S | Form 4 |
| IMVT |
Immunovant, Inc.
|
CTO
Sell to Cover
|
2025-10-22 | $47,956 | S | Form 4 |
|
IMVT
S
Immunovant, Inc.
Geffner Michael
• Officer • Chief Medical Officer
Sell to Cover
2025-10-22
$49,383
|
||||||
| IMVT |
Immunovant, Inc.
|
Officer • Chief Medical Officer
Sell to Cover
|
2025-10-22 | $49,383 | S | Form 4 |
| IMVT |
Immunovant, Inc.
|
CTO
Sell to Cover
|
2025-10-08 | $25,836 | S | Form 4 |
|
IMVT
S
Immunovant, Inc.
Geffner Michael
• Officer • Chief Medical Officer
Sell to Cover
2025-10-08
$20,734
|
||||||
| IMVT |
Immunovant, Inc.
|
Officer • Chief Medical Officer
Sell to Cover
|
2025-10-08 | $20,734 | S | Form 4 |